Myocardial infarction can cause irreversible heart muscle cell damage and lingering cardiac problems that can eventually lead to heart failure. For over a decade, researchers have been trying to coax stem cells to differentiate into cardiomyocytes to repair damaged heart tissue, with limited success. In 'Bedside to Bench', Christine L. Mummery and Richard T. Lee lay out a framework for re-evaluating cardiac cell therapies in the context of two recent clinical trials, in which autologous cardiac stem cells derived from heart biopsies were transferred into patients, with promising, albeit difficult to interpret, results. Results from previous clinical trials using autologous bone marrow–derived adult stem cells to induce cardiac regeneration add to the debate about how to cautiously move forward in the cardiac regeneration field and to the questions that need to be urgently answered at the bench. In 'Bench to Bedside', Young-Jae Nam, Kunhua Song and Eric N. Olson discuss a number of recent studies in rodents showing that cardiac fibroblasts can be reprogrammed, via miRNAs and a transcription factor 'cocktail', to express cardiac genes, which resulted in improved cardiac function in the animals, suggesting a new way forward for fixing damaged heart tissue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Passier, R., van Laake, L.W. & Mummery, C.L. Nature 453, 322–329 (2008).
van Laake, L.W. et al. Stem Cell Res. 1, 9–24 (2007).
Shiba, Y. et al. Nature 489, 322–325 (2012).
Ardehali, R. et al. Proc. Natl. Acad. Sci. USA 110, 3405–3410 (2013).
Chugh, A.R. et al. Circulation 126, S54–S64 (2012).
Makkar, R.R. et al. Lancet 379, 895–904 (2012).
Bearzi, C. et al. Proc. Natl. Acad. Sci. USA 104, 14068–14073 (2007).
Davis, D.R., Ruckdeschel Smith, R. & Marbán, E. Stem Cells 28, 903–904 (2010).
Wollert, K.C. et al. Lancet 364, 141–148 (2004).
Marbán, E. & Malliaras, K. J. Am. Med. Assoc. 308, 2405–2406 (2012).
Murry, C.E. et al. Nature 428, 664–668 (2004).
Balsam, L.B. et al. Nature 428, 668–673 (2004).
Martin-Rendon, E. et al. Cochrane Database Syst. Rev. CD006536 (2008).
Jopling, C. et al. Nature 464, 606–609 (2010).
Kikuchi, K. et al. Nature 464, 601–605 (2010).
Porrello, E.R. et al. Science 331, 1078–1080 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.T.L. is a founder of and consultant to Provasculon. C.L.M. is a founder of and consultant to Pluriomics.
Rights and permissions
About this article
Cite this article
Mummery, C., Lee, R. Is heart regeneration on the right track?. Nat Med 19, 412–413 (2013). https://doi.org/10.1038/nm.3158
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3158
